Contineum Therapeutics, Inc. Class A Common Stock (CTNM) short interest & short volume · 13.3% of float short
Contineum Therapeutics, Inc. Class A Common Stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
CTNM short interest rose 19.2% to 3.7M shares in the Oct 15, 2026 report (13.3% of float, 2.2 days to cover). Daily short volume averaged 55.3% of volume over the last 20 sessions, up from 44.1% the 20 sessions before, the 88th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 3.7M
- prior 3.1M
- % of float
- 13.3%
- float 27.6M
- Days to cover
- 2.2
- avg vol 1.6M
- Change vs prior report
- +19.2%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 75.8%
- 93K of 123K
- 20-day average
- 55.3%
- prior 44.1%
- Percentile vs own history
- 88th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: +22.7%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
CTNM's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · CTNM overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 93,493 | 123,399 | 75.8% |
| 2026-10-30 | 67,491 | 97,207 | 69.4% |
| 2026-10-29 | 131,658 | 217,440 | 60.5% |
| 2026-10-28 | 96,448 | 181,660 | 53.1% |
| 2026-10-27 | 183,762 | 231,455 | 79.4% |
| 2026-10-26 | 136,040 | 156,049 | 87.2% |
| 2026-10-23 | 115,467 | 154,932 | 74.5% |
| 2026-10-22 | 144,697 | 196,903 | 73.5% |
| 2026-10-21 | 348,234 | 551,963 | 63.1% |
| 2026-10-20 | 457,043 | 978,699 | 46.7% |
Healthcare peers with similar quant ratings
CTNM is rated 2.76 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- ALT short interest2.79 · Hold · stock
- NAGE short interest2.79 · Hold · stock
- DMAC short interest2.77 · Hold · stock
- IPSC short interest2.77 · Hold · stock
- PRCT short interest2.76 · Hold · stock
- DSGN short interest2.75 · Hold · stock
- ANRO short interest2.74 · Hold · stock
- ACOG short interest2.73 · Hold · stock
CTNM short interest FAQ
What is CTNM's short interest?
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) had 3.7M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 13.3% of its 27.6M-share float.
How many days to cover does CTNM have?
2.2 days: 3.7M shares short divided by an average daily volume of 1.6M for the Oct 15, 2026 period.
Is CTNM short interest rising or falling?
CTNM short interest rose (+19.2%) from 3.1M to 3.7M shares in the Oct 15, 2026 report.
Is CTNM a short squeeze candidate?
Lician's squeeze watch scores CTNM 47 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 17.7/40, days to cover 5.6/25, change in short interest vs prior report 5.7/15, price change since settlement date 18.2/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of CTNM daily volume is sold short?
55.3% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 88th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was CTNM's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) was 93,493 shares, 75.8% of 123,399 total volume.
How many CTNM short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Contineum Therapeutics, Inc. Class A Common Stock (CTNM), from Oct 20, 2026 through Nov 2, 2026.
How did CTNM short volume percent change from the prior cached session?
Cached FINRA short volume for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) moved from 69.4% on Oct 30, 2026 to 75.8% on Nov 2, 2026, up 6.4 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.